Introduction to Refractory Classic
Sentence Examples
Discover more insights into Refractory Classic
Keywords frequently search together with Refractory Classic
Narrow sentence examples with built-in keyword filters
Refractory Classic sentence examples within lymphoma r r
This systematic review and meta-analysis aimed to determine the effectiveness of brentuximab vedotin (BV) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) in the clinical practice setting using most recent results.
This systematic review and meta-analysis aimed to determine the effectiveness of brentuximab vedotin (BV) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) in the clinical practice setting using most recent results.
Full Text
7530 Background: Clinical trials of novel salvage therapies (ST) have encouraging outcomes for relapsed/refractory classic Hodgkin lymphoma (R/R cHL) eligible for autologous stem cell transplant (ASCT).
7530 Background: Clinical trials of novel salvage therapies (ST) have encouraging outcomes for relapsed/refractory classic Hodgkin lymphoma (R/R cHL) eligible for autologous stem cell transplant (ASCT).
Full Text
Refractory Classic sentence examples within autologous stem cell
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT).
The standard management for relapsed or refractory classical Hodgkin lymphoma (cHL) is salvage therapy followed by autologous stem cell transplantation (ASCT).
Full Text
e19516 Background: There are few optimized therapeutic options for relapsed and/or refractory classic Hodgkin’s lymphoma (r/rCHL), especially in patients who failed in treatments of autologous stem cell transplantation (ASCT), brentuximab vedotin or even immune checkpoint blockage.
e19516 Background: There are few optimized therapeutic options for relapsed and/or refractory classic Hodgkin’s lymphoma (r/rCHL), especially in patients who failed in treatments of autologous stem cell transplantation (ASCT), brentuximab vedotin or even immune checkpoint blockage.
Full Text
Refractory Classic sentence examples within stem cell transplantation
BACKGROUND
Relapsed or refractory classical Hodgkin lymphoma could be treated with multiagent salvage chemotherapy followed by autologous haematopoietic stem-cell transplantation.
BACKGROUND
Relapsed or refractory classical Hodgkin lymphoma could be treated with multiagent salvage chemotherapy followed by autologous haematopoietic stem-cell transplantation.
Full Text
Learn more from Refractory Classic
Refractory Classic sentence examples within Medically Refractory Classic
Methods: We prospectively recruited 14 medically refractory classical TN patients and 20 healthy subjects.
Methods: We prospectively recruited 14 medically refractory classical TN patients and 20 healthy subjects.
Full Text
Methods
We prospectively recruited 22 medically refractory classic or idiopathic TN patients undergoing surgical treatment over a 3-year period, and 19 age- and sex-matched healthy control subjects.
Methods
We prospectively recruited 22 medically refractory classic or idiopathic TN patients undergoing surgical treatment over a 3-year period, and 19 age- and sex-matched healthy control subjects.
Full Text
Refractory Classic sentence examples within refractory classic hodgkin
Clinical use of immune-checkpoints inhibitors (anti PD-1/PD-L1) resulted very effective for the treatment of relapsed/refractory classic Hodgkin Lymphoma (CHL).
Clinical use of immune-checkpoints inhibitors (anti PD-1/PD-L1) resulted very effective for the treatment of relapsed/refractory classic Hodgkin Lymphoma (CHL).
Full Text
Introduction Brentuximab vedotin (BV) and the PD-1 inhibitors, pembrolizumab and nivolumab, have dramatically improved therapeutic options in relapsed and refractory classic Hodgkin.
Introduction Brentuximab vedotin (BV) and the PD-1 inhibitors, pembrolizumab and nivolumab, have dramatically improved therapeutic options in relapsed and refractory classic Hodgkin.
Full Text
More Refractory Classic sentence examples
10.1007/s40265-021-01628-5
Based on the results of a phase II trial, zimberelimab was recently approved for marketing in China as treatment for relapsed or refractory classical Hodgkin’s lymphoma.
Based on the results of a phase II trial, zimberelimab was recently approved for marketing in China as treatment for relapsed or refractory classical Hodgkin’s lymphoma.
Full Text
More Refractory Classic sentence examples
10.1038/s41598-021-86655-8
Clinical use of immune-checkpoints inhibitors (anti PD-1/PD-L1) resulted very effective for the treatment of relapsed/refractory classic Hodgkin Lymphoma (CHL).
Clinical use of immune-checkpoints inhibitors (anti PD-1/PD-L1) resulted very effective for the treatment of relapsed/refractory classic Hodgkin Lymphoma (CHL).
Full Text
More Refractory Classic sentence examples
10.1016/S2152-2650(21)01251-9
Introduction Brentuximab vedotin (BV) and the PD-1 inhibitors, pembrolizumab and nivolumab, have dramatically improved therapeutic options in relapsed and refractory classic Hodgkin.
Introduction Brentuximab vedotin (BV) and the PD-1 inhibitors, pembrolizumab and nivolumab, have dramatically improved therapeutic options in relapsed and refractory classic Hodgkin.
Full Text
More Refractory Classic sentence examples
10.1200/JCO.2021.39.15_SUPPL.E19515
e19515 Background: The anti-PD-1 combination therapy significantly improves clinical outcomes in patients with relapsed/refractory classical Hodgkin lymphoma (cHL), and up to 71% of patients who receive decitabine-plus-anti-PD-1 camrelizumab could achieve a complete response.
e19515 Background: The anti-PD-1 combination therapy significantly improves clinical outcomes in patients with relapsed/refractory classical Hodgkin lymphoma (cHL), and up to 71% of patients who receive decitabine-plus-anti-PD-1 camrelizumab could achieve a complete response.
Full Text
More Refractory Classic sentence examples
10.1158/1078-0432.CCR-21-0133
Purpose: Programmed death-1 (PD-1) blockade monotherapy is effective in relapsed/refractory classical Hodgkin lymphoma (cHL), but a subset of patients is recalcitrant to PD-1 inhibitors and only a minority of patients achieves durable remission.
Purpose: Programmed death-1 (PD-1) blockade monotherapy is effective in relapsed/refractory classical Hodgkin lymphoma (cHL), but a subset of patients is recalcitrant to PD-1 inhibitors and only a minority of patients achieves durable remission.
Full Text
More Refractory Classic sentence examples
10.21320/2500-2139-2021-14-1-53-62
Checkpoint inhibitors contribute to improving the treatment outcomes in patients with relapsed/refractory classical Hodgkin’s lymphoma (cHL).
Checkpoint inhibitors contribute to improving the treatment outcomes in patients with relapsed/refractory classical Hodgkin’s lymphoma (cHL).
Full Text
More Refractory Classic sentence examples
10.1038/s41375-021-01193-6
Anti-PD-1 monoclonal antibodies yield high response rates in patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but most patients will eventually progress.
Anti-PD-1 monoclonal antibodies yield high response rates in patients with relapsed/refractory classic Hodgkin lymphoma (cHL), but most patients will eventually progress.
Full Text
More Refractory Classic sentence examples
10.1016/S2352-3026(21)00103-4
BACKGROUND
Novel approaches are required to improve outcomes in relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma.
BACKGROUND
Novel approaches are required to improve outcomes in relapsed or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma.
Full Text
More Refractory Classic sentence examples
10.1200/OP.20.00771
The checkpoint inhibitors nivolumab and pembrolizumab are principal treatment options for relapsed or refractory classic Hodgkin lymphoma.
The checkpoint inhibitors nivolumab and pembrolizumab are principal treatment options for relapsed or refractory classic Hodgkin lymphoma.
Full Text
More Refractory Classic sentence examples
10.3389/fphar.2021.733890
Concerning hematological malignancies, only nivolumab and pembrolizumab have been approved for the treatment of relapsed and refractory classical Hodgkin lymphoma and primary mediastinal large B cell lymphoma to date.
Concerning hematological malignancies, only nivolumab and pembrolizumab have been approved for the treatment of relapsed and refractory classical Hodgkin lymphoma and primary mediastinal large B cell lymphoma to date.
Full Text
More Refractory Classic sentence examples
10.12998/wjcc.v9.i21.6041
BACKGROUND Academic studies have proved that anti-programmed death-1 (PD-1) monoclonal antibodies demonstrated remarkable activity in relapsed/refractory classical Hodgkin lymphoma (cHL).
BACKGROUND Academic studies have proved that anti-programmed death-1 (PD-1) monoclonal antibodies demonstrated remarkable activity in relapsed/refractory classical Hodgkin lymphoma (cHL).
Full Text
More Refractory Classic sentence examples
10.1038/s41375-021-01167-8
We experienced three cases of chemotherapy-refractory classical Hodgkin lymphoma, those were treated by nivolumab as a salvage therapy and followingly received HLAhaploidentical HSCT.
We experienced three cases of chemotherapy-refractory classical Hodgkin lymphoma, those were treated by nivolumab as a salvage therapy and followingly received HLAhaploidentical HSCT.
Full Text
More Refractory Classic sentence examples
10.1530/JOE-21-0209
Checkpoint inhibitor pembrolizumab (KEYTRUDA), a chimeric antibody which targets programmed cell death protein 1 (PD-1), has been approved by the FDA for use in pediatric patients with relapsed or refractory classical Hodgkin's lymphoma.
Checkpoint inhibitor pembrolizumab (KEYTRUDA), a chimeric antibody which targets programmed cell death protein 1 (PD-1), has been approved by the FDA for use in pediatric patients with relapsed or refractory classical Hodgkin's lymphoma.
Full Text
More Refractory Classic sentence examples
10.21037/tau-21-268
Camrelizumab is a programmed cell death protein 1 (PD-1) inhibitor which has been approved for the treatment of recurrent or refractory classical Hodgkin lymphoma in China and have achieved improvement in a verity of solid tumors with manageable safety profile.
Camrelizumab is a programmed cell death protein 1 (PD-1) inhibitor which has been approved for the treatment of recurrent or refractory classical Hodgkin lymphoma in China and have achieved improvement in a verity of solid tumors with manageable safety profile.
Full Text
More Refractory Classic sentence examples
10.2174/1574892816666210208231744
It is used for the treatment of complicated or refractory classic Hodgkin's lymphoma with at least second-line chemotherapy.
It is used for the treatment of complicated or refractory classic Hodgkin's lymphoma with at least second-line chemotherapy.
Full Text
More Refractory Classic sentence examples
10.1016/S1470-2045(21)00005-X
BACKGROUND
PD-1 blockade via pembrolizumab monotherapy has shown antitumour activity and toxicity in patients with relapsed or refractory classical Hodgkin lymphoma.
BACKGROUND
PD-1 blockade via pembrolizumab monotherapy has shown antitumour activity and toxicity in patients with relapsed or refractory classical Hodgkin lymphoma.
Full Text
More Refractory Classic sentence examples
10.1182/blood.2020009178
This phase 1-2 study evaluated brentuximab vedotin (BV) combined with nivolumab (Nivo) as first salvage therapy in patients with relapsed or refractory classical Hodgkin lymphoma.
This phase 1-2 study evaluated brentuximab vedotin (BV) combined with nivolumab (Nivo) as first salvage therapy in patients with relapsed or refractory classical Hodgkin lymphoma.
Full Text
More Refractory Classic sentence examples
10.1136/jitc-2021-002347
Background Programmed death-1 (PD-1) blockade monotherapy induced durable remission in a subset of patients with relapsed/refractory classical Hodgkin lymphoma (cHL).
Background Programmed death-1 (PD-1) blockade monotherapy induced durable remission in a subset of patients with relapsed/refractory classical Hodgkin lymphoma (cHL).
Full Text
More Refractory Classic sentence examples
10.1007/s11899-021-00604-w
There are limited treatment options for relapsed/refractory classical Hodgkin lymphoma (cHL) patients who progress on brentuximab vedotin and programmed death-1 inhibitors.
There are limited treatment options for relapsed/refractory classical Hodgkin lymphoma (cHL) patients who progress on brentuximab vedotin and programmed death-1 inhibitors.
Full Text
Learn more from Refractory Classic
Keywords related to Refractory
Refractory Hypoglycaemia
Refractory Gerd
Refractory Congestive
Refractory Autoimmune
Refractory Seizures
Refractory Neurogenic
Refractory Breathlessness
Refractory Corrosion
Refractory Relapsed Diffuse
Refractory Material
Refractory Neuropathic
Refractory Intracranial
Refractory Macular
Refractory Symptoms
Refractory Epilepsies
Refractory Constipation
Refractory Ceramics
Refractory Obsessive Compulsive
Refractory Chylothorax
Refractory Migraine
Refractory Metals
Refractory Black
Refractory Hypoxia
Refractory Psoriatic
Refractory Organics
Refractory Pruritus
Refractory Cytomegalovirus
Refractory Multi Principal
Refractory Recurrent
Refractory Overactive
Refractory Primary
Refractory Colorectal
Refractory Wilms
Refractory Multiple
Refractory Focal
Refractory Atrial
Refractory B
Refractory Ulcerative
Refractory Infection
Refractory Major
Refractory Relapsed Multiple
Refractory Mutation
Refractory Castable
Refractory Melasma
Refractory Cardiogenic
Refractory Functional
Refractory Heart
Refractory Allergic
Refractory Concretes
Refractory Urgency
Explore More
Refractory Classic
Encyclopedia